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DISSERTATION
The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus 1. Abstrakt
Abstrakt in Englisch
The Impact of Insulin-independent Glucagon-induced Suppression of Total-
Ghrelin on Satiety in Obesity and Type 1 Diabetes mellitus

Aims/hypothesis
The mechanisms underlying the glucagon-induced satiety effect are unclear. We have shown earlier that glucagon induces a remarkable decrease in total-ghrelin, which is a 28-amino acid gastric peptide known to regulate feeding behavior and adiposity. We also demonstrated that these effects are exerted at brain-hypothalamo-pituitary level. The aim of our current work was to further investigate glucagon-suppressive effects on circulating total-and acylated-ghrelin, both in obesity and in type 1 diabetes (T1DM), with respect to the role of glucagon in appetite control. We further aimed to identify a possible mechanistic impact of changes in endogenous insulin.
Methods
In our prospective, double-blinded, placebo-controlled study, we investigated the endocrine and metabolic responses to intramuscular glucagon administration in 13 .
Results
Plasma glucagon increased significantly after i.m. glucagon administration by ~ 8-9
fold in all study groups and returned to baseline levels by 240 minutes. Insulin levels increased with a peak after 30 minutes followed by a decrease towards baseline level after 120 minutes in OP and LP (p<0.01), but did not change in patients with T1DM.
As compared to placebo, glucagon significantly increased satiety index (SI) in T1DM
and in LP (p<0.001), but failed to induce satiety in OP (p=0.152). The glucagon-induced satiety response was even detectable after 24-h of administration in LP and T1DM (p<0.01) but not in OP (p>0.05). Total-ghrelin significantly decreased after glucagon administration in all study groups (p<0.01). Similarly, acylated-ghrelin significantly decreased in LP (p<0.01). However, acylated-ghrelin concentrations showed no change in OP (p=0.248) and even increased substantially in T1DM (p<0.01). Changes in acylatedghrelin correlated positively with changes in NEFA concentrations in all groups (r=0.31-0.43; p<0.01).
Conclusions/interpretation
Herein we present novel data showing that intramuscular administration of glucagon significantly decreased circulating total-ghrelin in both lean and obese participants and in patients with T1DM, suggesting a mechanism that is independent of endogenous insulin levels. We also show that glucagon-induced satiety effects were preserved in T1DM, but were lost in obesity despite an intact hypothalamic-pituitary axis. The insulin-independent impact of glucagon on satiety was not mediated by changes in both total-and acyl-ghrelin, which however appeared to be more related to glucagon and /or insulin-induced modification of lipolysis. • Erstellung von Statistik.
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